Subject
Clinical Microbiology Reviews is a peer-reviewed medical journal covering the areas of clinical microbiology, immunology, medical microbiology, infectious diseases, veterinary microbiology, and microbial pathogenesis. It is a delayed open access journal, full content is accessible via PubMed Central and the journal's website after a 12-month embargo. In April 2015, the journal transitioned to a continuous online publication model (whereby articles are published as they become ready, before the issue in which they will appear has been finalized). The journal became online-only in January 2018. The final print issue was published in October 2017. According to the Journal Citation Reports, the journal has a 2021 impact factor of 50.129. The journal was established in January 1988. The founding editor was Josephine A. Morello (University of Chicago Medical Center). Editorial board structure changed in 1992 and Morello became editor-in-chief. Betty Ann Forbes (State University of New York) was appointed editor-in-chief in 1997. Irving Nachamkin (University of Pennsylvania) was appointed editor-in-chief in 2002 until 2012. Jo-Anne H. Young (University of Minnesota) served as editor-in-chief from 2012 to 2022. The current editor-in-chief is Graeme Forrest (Rush University). It is the ninth journal established and published by the American Society for Microbiology. Source: Wikipedia (en)
Editions published in Clinical Microbiology Reviews 200
-
Zika Virus
-
Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis
-
Norovirus
-
A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics
-
Pneumococcal Capsules and Their Types: Past, Present, and Future
-
Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans
-
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future
-
Cryptococcus gattii infections
-
Evidence and implications of mortality associated with acute Plasmodium vivax malaria
-
Transmission and epidemiology of zoonotic protozoal diseases of companion animals
-
Cryptosporidium pathogenicity and virulence
-
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation
-
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents
-
Clinical application of volatile organic compound analysis for detecting infectious diseases
-
Salivary biomarkers: toward future clinical and diagnostic utilities
-
A comprehensive, model-based review of vaccine and repeat infection trials for filariasis
-
Intruders below the radar: molecular pathogenesis of Bartonella spp
-
Bed bugs: clinical relevance and control options
-
The Cryptococcus neoformans capsule: a sword and a shield
-
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
-
Helminth infections and host immune regulation
-
West Nile Virus: biology, transmission, and human infection
-
Stenotrophomonas maltophilia: an emerging global opportunistic pathogen
-
Progress and problems in understanding and managing primary Epstein-Barr virus infections
-
Sporothrix schenckii and Sporotrichosis
-
Human Metapneumovirus: lessons learned over the first decade
-
Current knowledge of Trichosporon spp. and Trichosporonosis
-
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic
-
Melanized fungi in human disease
-
Role of bacteria in oncogenesis
-
Three decades of beta-lactamase inhibitors
-
The genus Aeromonas: taxonomy, pathogenicity, and infection
Subject - wd:Q5133777